首页> 美国卫生研究院文献>Journal of Virology >The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.
【2h】

The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.

机译:人类2型免疫缺陷病毒(HIV)包膜蛋白是1型HIV Vpu的功能性补体可增强异源逆转录病毒的颗粒释放。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have recently shown that the envelope glycoprotein of the ROD10 isolate of human immunodeficiency virus type 2 (HIV-2) has the ability to positively regulate HIV-2 viral particle release. The activity provided by the ROD10 Env was remarkably similar to that of the HIV-1 Vpu protein, thus raising the possibility that the two proteins act in a related fashion. We now show that the ROD10 Env can functionally replace Vpu to enhance the rate of HIV-1 particle release. When provided in trans, both Vpu and the ROD10 Env restored wild-type levels of particle release in a Vpu-deficient mutant of the NL4-3 molecular clone with indistinguishable efficiencies. This effect was independent of the presence of the HIV-1 envelope protein. The ROD10 Env also enhanced HIV-1 particle release in the context of HIV-2 chimeric viruses containing the HIV-1 gag-pol, indicating a lack of need for additional HIV-1 products in this process. In addition, we show for the first time that HIV-1 Vpu, as well as ROD10 Env, has the ability to enhance simian immunodeficiency virus (SIV) particle release. The effects of Vpu and ROD10 Env on SIV particle release were indistinguishable and were observed in the context of full-length SIVmac239 and simian-human immunodeficiency virus chimeras. These results further demonstrate that ROD10 Env can functionally complement Vpu with respect to virus release. In contrast, we found no evidence of a destabilizing activity of ROD10 Env on the CD4 molecule. HIV-1 and HIV-2 thus appear to have evolved genetically distinct but functionally similar strategies to resolve the common problem of efficient release of progeny virus from infected cells.
机译:我们最近显示,人类2型免疫缺陷病毒(HIV-2)的ROD10分离物的包膜糖蛋白具有积极调节HIV-2病毒颗粒释放的能力。 ROD10 Env提供的活性与HIV-1 Vpu蛋白的活性非常相似,因此增加了这两种蛋白以相关方式起作用的可能性。我们现在显示ROD10 Env可以在功能上替代Vpu,以提高HIV-1颗粒释放的速率。当以反式提供时,Vpu和ROD10 Env都以无法区分的效率恢复了NL4-3分子克隆的Vpu缺陷型突变体中颗粒释放的野生型水平。此效果与HIV-1包膜蛋白的存在无关。在含有HIV-1 gag-pol的HIV-2嵌合病毒的情况下,ROD10 Env还增强了HIV-1颗粒的释放,表明在此过程中不需要其他HIV-1产品。此外,我们首次展示了HIV-1 Vpu以及ROD10 Env具有增强猿猴免疫缺陷病毒(SIV)颗粒释放的能力。 Vpu和ROD10 Env对SIV颗粒释放的影响是无法区分的,并且在全长SIVmac239和猿猴-人免疫缺陷病毒嵌合体的情况下可以观察到。这些结果进一步证明,ROD10 Env在病毒释放方面可以在功能上补充Vpu。相反,我们没有发现ROD10 Env对CD4分子具有破坏稳定作用的证据。因此,HIV-1和HIV-2似乎在进化上具有遗传上独特但在功能上相似的策略,以解决从感染细胞有效释放子代病毒的普遍问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号